Results 111 to 120 of about 6,025 (196)

Efficacy and Safety of Tenecteplase in Acute Ischemic Stroke: A Meta‐Analysis of Randomized Controlled Trials

Brain and Behavior
Introduction Acute ischemic stroke (AIS) is the most common type of stroke, with increasing incidence and significant healthcare costs. Tenecteplase (TNK), a modified variant of tissue plasminogen activator (tPA), offers advantages such as a longer half ...
Zaryab Bacha, Javeria Javed, Maheen Sheraz, Muhammad Abdullah Ali, M. Ehtisham Wali Khan, Sufyan Shahid, Asad Iqbal, Mahnoor Qasim, Abdullah Afridi, Fazia Khattak, Fathimathul Henna, Mazhar Ali Shah, Raheel Ahmed   +12 more
doaj   +1 more source

Outcome of bioprosthetic valve replacement in dogs with tricuspid valve dysplasia [PDF]

, 2017
Adin, Arai, Attenhofer Jost, Bloomfield, Brennan, Famula, Funayama, Griffiths, Liu, Massel, Monnet, Nakayama, Oliveira, Orton, Orton, Uechi   +15 more
core   +2 more sources

''Sugar for the Heart'', a bitter pill for tenecteplase: the crystallisation trap of pre-hospital fibrinolysis. [PDF]

Scand J Trauma Resusc Emerg Med
Prevautel T, Adet A, Michoud G.
europepmc   +1 more source

Comparison of the efficacy and safety of different thrombolytic drugs in the treatment of acute ischemic stroke within 4.5 h: a systematic review and network meta-analysis. [PDF]

Front Neurol
Yu X, Liu J, Shi C, Xue D, Jiang Y, Wang W, Zhao M.   +6 more
europepmc   +1 more source

Tenecteplase for thrombolysis of acute ischemic stroke in a 68-year-old woman. [PDF]

CMAJ
Khan F, Yogendrakumar V, Ignacio KH, Menon BK, Hill MD.   +4 more
europepmc   +1 more source

Efficacy and safety of tenecteplase versus urokinase in the treatment of acute ischemic stroke. [PDF]

Medicine (Baltimore)
Li D, Huang S, Wang X, Hong Z, Qiu X.
europepmc   +1 more source

Thrombolytic agents, more options, more challenges. [PDF]

Stroke Vasc Neurol
Dong Y, Xu L, Hong L, Liu Y, Tu W, Zheng H, Leng X, Xiong Y, Cheng X, Wang DZ.   +9 more
europepmc   +1 more source

Comparing Clinical Characteristics and Outcomes of Tenecteplase Versus Alteplase in Young Adult Patients With Stroke: A Secondary Analysis of the AcT Trial. [PDF]

Stroke Vasc Interv Neurol
Ignacio KHD, Bala F, Catanese L, Tkach A, Kate M, Buck B, Ademola A, Sajobi TT, Field TS, Pikula A, Shamy M, Hunter G, Swartz RH, Horn M, Dowlatshahi D, Shankar JJ, Hill MD, Menon BK, Almekhlafi MA, Singh N.   +19 more
europepmc   +1 more source

Translational Stroke Research Using a Rabbit Embolic Stroke Model: A Correlative Analysis Hypothesis for Novel Therapy Development [PDF]

, 2010
Paul A. Lapchak, T Ingall, D Lloyd-Jones, GW Petty, GW Petty, PA Lapchak, PA Lapchak, U Dirnagl, P Michel, RR Moustafa, M Fisher, PD Schellinger, PD Schellinger, M Verstraete, W Hacke, MG Lansberg, The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, MD Ginsberg, A Shuaib, EL Bailey, R Prieto-Arribas, GZ Feuerstein, A Durukan, R Hua, ST Carmichael, S Fukuda, RJ Traystman, P Lyden, P Lyden, G Sulter, JT Wilson, FB Young, JA Zivin, DA Phillips, DA Phillips, BB Chehrazi, CE Gross, PA Lapchak, PA Lapchak, PA Lapchak, GA Matchett, M Kawaguchi, IP Koerner, PA Lapchak, PA Lapchak, PA Lapchak, PA Lapchak, L Zhang, M Asahi, T Kano, T Kano, P Meden, K Overgaard, GW Albers, MJ Alberts, I Christou, WM Clark, JC Grotta, JC Grotta, W Hacke, W Hacke, JR Marler, P Zunker, AW Hsia, G Zoppo del, JW Marshall, JW Marshall, JW Marshall, J Peeling, SG Sydserff, Z Zhao, PA Lapchak, S Kuroda, AR Green, PM Bath, PA Lapchak, KR Lees, T Watanabe, H Yoshida, K Toyoda, M Mishina, Y Inatomi, EAISG, S Suda, HC Diener, M Sinha, A Hishida, L Detaboada, S Ilic, A Oron, PA Lapchak, Y Lampl, JA Zivin, GJ Zoppo Del, Y Kitagawa, J Karbowski, S Gelineo, Z Zhang, N Henninger   +98 more
core   +1 more source

Response to the letter to the editor regarding "safety of tenecteplase versus alteplase for intravenous thrombolysis in acute ischemic stroke patients with direct oral anticoagulation". [PDF]

Neurol Res Pract
Mers L, Gerner ST.
europepmc   +1 more source